Rich Stuart 4
4 · TENAX THERAPEUTICS, INC. · Filed Jun 15, 2021
Insider Transaction Report
Form 4
Rich Stuart
DirectorChief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-06-11+3,581,000→ 4,243,517 total - Exercise/Conversion
Series B Preferred Stock
2021-06-11−3,581→ 0 totalFrom: 2021-06-11Exp: 2021-06-11→ Common Stock (3,581,000 underlying)
Footnotes (2)
- [F1]On June 10, 2021, the shareholders of Tenax Therapeutics, Inc. voted in favor of the conversion of all Series B Preferred Stock to Common Stock. Pursuant to this action, all Series B Preferred Stock owned by the Reporting Person converted automatically to shares of Common Stock on June 11, 2021.
- [F2]As described further in Note 1, above, the disposition of the Series B Preferred Stock and the acquisition of Common Stock occurred pursuant to an automatic conversion; as such, no consideration was paid to or payable by the Reporting Person pursuant to this transaction.